There are 594 resources available
357P - Association of TROP2 quantitative continuous scoring (QCS) normalised membrane ratio (NMR) with efficacy in Chinese patients (pts) with advanced/metastatic non-small cell lung cancer (a/mNSCLC) treated with datopotamab deruxtecan (Dato-DXd) in TROPION-PanTumor02
Presenter: Yi-Long Wu
Session: Poster Display session
358P - Baseline circulating immunophenotype may predict irAEs onset in NSCLC patients treated with ICIs
Presenter: Alessandra Dodi
Session: Poster Display session
359P - Prognostic role of B7H3 in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Presenter: Xinxin Zhi
Session: Poster Display session
360P - Lymphocyte activation gene-3 (LAG-3) and cluster of differentiation-155 (CD-155) expression by immunohistochemistry do not predict response and survival in non-small lung cancer (NSCLC) patients treated with second-line nivolumab treatment
Presenter: Aslihan Ezgi Apaydin
Session: Poster Display session
361P - Microbiota biomarkers as predictors of immunotherapy response in patients with advanced non-small cell lung cancer
Presenter: Juan Vicente-Valor
Session: Poster Display session
362P - LIPI score in advanced NSCLC treated with ICIs: Prognostic impact and blood immune-inflammatory correlations
Presenter: Martina Manini
Session: Poster Display session
363P - Retrospective evaluation of biomarkers (KRAS, TP53, STK11, KEAP1, POLE, PIK3CA and ARID1A) in pts with mNSCLC undergoing ICI mono or in combination with chemotherapy
Presenter: Julia Roeper
Session: Poster Display session
364P - Relationship of LIPI index and C-reactive protein with survival in a cohort of patients with advanced non-small cell lung carcinoma (NSCLC) treated with immunotherapy
Presenter: Raquel Manjon Gomez
Session: Poster Display session
365P - Association of TP53 mutation in liquid biopsy with clinical characteristics and prognosis in metastatic non-small cell lung cancer (NSCLC)
Presenter: Jose Fuentes Pradera
Session: Poster Display session
366P - Tumor derived exosomes in mediating cross-talk between PBMCs and EGFR mutant NSCLC cells and their role in osimertinib resistance
Presenter: Luisa Amato
Session: Poster Display session
Resources:
Abstract